BlueRock Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
25
About the Report
About the Report
Summary
BlueRock Therapeutics is a biotechnology company that develops novel stem cell therapies to treat cardiovascular and neurodegenerative diseases. The company's therapeutic candidate is used to treat Parkinson's disease that restores dopamine production in the midbrain by retaining dopamine-secreting cells which are affected due to degenerative disease conditions. It also develops cardiomyocytes which are lost during the heart attack in an infarcted heart to remuscularize the heart. BlueRock Therapeutics' therapeutic platform is based on induced pluripotent stem cells which can be generated from cells in a normal blood draw from a consenting adult and produced using cell manufacturing technologies. The company has operations in Canada and the US. BlueRock Therapeutics is headquartered in Toronto, Ontario, Canada.
BlueRock Therapeutics-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
BlueRock Therapeutics, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BlueRock Therapeutics Raises USD225 Million in Series A Financing 10
Partnerships 11
BlueRock Therapeutics Enters into Research Partnership with Memorial Sloan Kettering Cancer Center 11
Licensing Agreements 12
BlueRock Therapeutics Enters into Licensing Agreement with Universal Cells 12
BlueRock Therapeutics Enters into Licensing Agreement with VistaGen Therapeutics 13
Equity Offering 14
BlueRock Therapeutics Spins Out from Kyoto University 14
BlueRock Therapeutics-Key Competitors 15
BlueRock Therapeutics-Key Employees 16
BlueRock Therapeutics-Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Oct 26, 2017: BlueRock Therapeutics Establishes Corporate Headquarters in Cambridge, Massachusetts and Bolsters Team to Support Rapid Growth and Development 18
Aug 17, 2017: BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership 19
Corporate Communications 20
Sep 20, 2018: BlueRock Therapeutics names Shane Kovacs as chief business and financial officer 20
Dec 01, 2017: BlueRock Therapeutics Announces Appointment of Derek Hei, Ph.D. as Senior VP, Manufacturing, Quality and Regulatory 21
Jun 27, 2017: BlueRock Therapeutics Announces Key Members of Executive Team 22
Government and Public Interest 23
Jan 05, 2018: Get to Know the Revolutionary Medical Innovations Being Unleashed in Canada 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List of Figure
List of Figures
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Key Facts 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Deals By Therapy Area, 2012 to YTD 2018 8
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BlueRock Therapeutics Raises USD225 Million in Series A Financing 10
BlueRock Therapeutics Enters into Research Partnership with Memorial Sloan Kettering Cancer Center 11
BlueRock Therapeutics Enters into Licensing Agreement with Universal Cells 12
BlueRock Therapeutics Enters into Licensing Agreement with VistaGen Therapeutics 13
BlueRock Therapeutics Spins Out from Kyoto University 14
BlueRock Therapeutics, Key Competitors 15
BlueRock Therapeutics, Key Employees 16
BlueRock Therapeutics, Other Locations 17
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.